Procter & Gamble Health Peer Comparison

NSE: PGHL | BSE: 500126

₹5,406.00

₹-10.50 (-0.19%)

As on 25-Sep-2026IST

Market cap

₹8,967 Cr

Revenue (TTM)

₹1,433 Cr

P/E Ratio

25.1

P/B Ratio

14.6

Div. Yield

3.8 %

Edit

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	8,967	21,422	19,810	17,460	18,299
Revenue (₹ Cr)	1,433	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	356.88	678.07	273.51	666.92	735.15
Net Margin (%)	24.61	28.10	16.19	20.60	26.88
RoE (%)	58.24	19.73	11.15	18.75	19.16
Price to Earnings	25.13	32.20	66.63	27.12	24.89
Price-To-Book	14.57	5.83	7.37	4.33	4.15

Income Statement (₹ Cr)

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	1,432.94	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	1,450.13	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	967.02	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	465.92	796.58	478.55	1,139.61	941.63
Depreciation	24.17	78.10	126.01	281.06	57.58
EBIT	441.75	718.48	352.55	858.55	884.05
Interest	0.57	0.88	52.11	190.64	7.69
Other Income	17.19	125.96	7.37	7.45	165.62
Exceptional Items	31.80	0.00	12.16	-17.24	-49.16
Profit before Tax	490.17	843.56	319.96	658.12	992.82
Provision for Tax	133.29	165.49	46.45	-8.80	257.67
Profit after Tax	356.88	678.07	273.51	666.92	735.15

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	524.55	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	61.87	28.74	266.35	1,392.75	91.50
Current Liabilities	254.93	385.94	848.06	2,077.10	627.48
Total Liabilities	841.35	4,037.51	3,705.61	7,246.72	4,921.88

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	150.47	1,291.22	2,525.44	5,617.77	770.28
Current Assets	556.26	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	841.35	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	0.00	0.57	657.97	2,309.68	2.50
Net Current Assets	301.33	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	174.73	17.53	160.01	51.57	370.49

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	337.79	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	1.26	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	-343.92	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	-4.87	-105.52	29.88	-145.00	-392.41

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	84.86	24.97	11.43	14.47	23.39
ROE (%)	58.24	19.73	11.15	18.75	19.16
ROA (%)	43.64	18.69	7.80	9.26	14.95
EBIT Margin (%)	30.83	31.41	20.95	26.58	34.40
Net Margin (%)	24.61	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	12.57	15.01	27.91	9.59	10.69
EBIT Growth (%)	14.27	18.45	58.32	16.84	24.14
Net Profit Growth (%)	18.73	19.61	149.56	62.68	-9.09
EPS Growth (%)	10.85	17.73	-3.57	67.41	14.40
Book Value Growth (%)	-2.37	26.75	9.67	36.71	-0.34

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	27.01	32.25	71.20	26.46	23.69
Price / Book Value	14.62	5.84	7.43	4.34	4.15
Dividend Yield (%)	3.78	0.28	0.06	0.00	1.88
EV/EBITDA	18.92	25.67	42.98	17.31	16.11
Market Cap (₹ Cr)	7,964.89	11,439.22	6,819.66	17,980.08	21,592.90

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	--	0.00	0.16	0.12	0.00
Current Ratio	2.18	6.70	1.31	0.74	6.06
Quick Ratio	1.65	5.59	0.88	0.53	5.31
Interest Coverage	860.95	959.59	7.14	4.45	130.11

	Procter & Gamble Health	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	11.46	36.10	30.84	21.07	7.07
Asset Turnover	1.75	0.63	0.48	0.45	0.52
Receivable days	36.06	121.68	113.81	63.88	26.06
Inventory Days	28.65	63.83	84.76	43.27	65.95
Payable days	181.85	108.28	101.94	151.85	81.01
Cash Conversion Cycle	-117.14	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.